SEAGEN INC
SEAGEN INC
Share · US81181C1045 · SGEN · A2QFAQ (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % 54,15 %

Company Profile for SEAGEN INC Share

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Invested Funds

The following funds have invested in: SEAGEN INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
948,47
Percentage (%)
2,23 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
1.005,68
Percentage (%)
0,28 %
Fund
iShares Nasdaq 100 UCITS ETF EUR Hedged (Acc)
Vol. in million
361,03
Percentage (%)
0,19 %
Fund
iShares NASDAQ-100® UCITS ETF (DE)
Vol. in million
6.457,49
Percentage (%)
0,19 %
Fund
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Dist)
Vol. in million
3,10
Percentage (%)
0,11 %

Company Data

Name SEAGEN INC
Company Seagen Inc.
Symbol SGEN
Website https://www.seagen.com
Primary Exchange XNAS NASDAQ
WKN A2QFAQ
ISIN US81181C1045
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. David R. Epstein B.Sc., M.B.A.
Market Capitalization 43 Mrd.
Country United States of America
Currency USD
Employees 3,3 T
Address 21823 30th Drive SE, 98021 Bothell
IPO Date 2001-03-09

Ticker Symbols

Name Symbol
NASDAQ SGEN

More Shares

Investors who SEAGEN INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DEXCO INC
DEXCO INC Share
HANSAINTERNATIONAL CL. A
HANSAINTERNATIONAL CL. A Fund
INTEL CORP
INTEL CORP Share
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NETFLIX INC
NETFLIX INC Share
OCCIDENTAL PETROLEUM CORP
OCCIDENTAL PETROLEUM CORP Share
SIEMENS FIN 20/32 MTN
SIEMENS FIN 20/32 MTN Bond
TRANSURBAN FIN.CO 15/25
TRANSURBAN FIN.CO 15/25 Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025